OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002361$18.2957

Anhui Shenjian New Materials Co Ltd

Commodity ChemicalsVerified

The company's capital structure is characterized by a debt-to-equity ratio of 0.65, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.3, suggesting limited short-term liquidity cushion. The price-to-book ratio of 7.92 and price-to-tangible-book ratio of 7.92 indicate that the company's market value is significantly higher than its book value, which may reflect market expectations of future growth or intangible assets not captured in the balance sheet. Profitability metrics show a weak performance, with a return on equity (ROE) of 0.61% and a return on assets (ROA) of 0.29%, both well below the typical thresholds for healthy returns in the Commodity Chemicals industry. Operating income was negative at -4.66 million CNY, while net income was a modest 13.3 million CNY, indicating that the company is barely profitable despite generating revenue of 2.42 billion CNY. Geographically and segment-wise, the company's exposure is not explicitly detailed in the available data, but the revenue concentration in a single business line (chemicals) suggests a high degree of operational risk. The absence of disclosed geographic diversification or segment breakdowns implies that the company's performance is highly sensitive to regional demand and supply chain disruptions. The company's growth trajectory is uncertain, with no clear revenue growth or margin expansion evident in the latest financials. Capital expenditures were negative at -44.04 million CNY, suggesting asset disposals or underinvestment in growth. Analyst estimates for revenue and EPS are aligned with the reported figures, indicating a lack of upward revision in expectations. Risk factors include a negative net cash position after subtracting total debt, which raises concerns about liquidity and financial flexibility. The company's dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the high price-to-earnings ratio of 1,308.03 and negative EV/EBITDA of -4,038.35 suggest that the stock is not currently valued based on earnings or cash flow generation. Recent events, including filings and transcripts, are not detailed in the available data, but the company's financial performance and capital structure suggest a need for close monitoring of liquidity and operational efficiency. The absence of positive operating cash flow and the presence of negative free cash flow further highlight the need for strategic capital management.

30-day price · 002361+2.05 (+13.4%)
Low$14.80High$23.95Close$17.30As of22 May, 00:00 UTC
Profile
CompanyAnhui Shenjian New Materials Co Ltd
Ticker002361.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Anhui Shenjian New Materials Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and manufacturing clients.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

The company's capital structure is characterized by a debt-to-equity ratio of 0.65, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.3, suggesting limited short-term liquidity cushion. The price-to-book ratio of 7.92 and price-to-tangible-book ratio of 7.92 indicate that the company's market value is significantly higher than its book value, which may reflect market expectations of future growth or intangible assets not captured in the balance sheet. Profitability metrics show a weak performance, with a return on equity (ROE) of 0.61% and a return on assets (ROA) of 0.29%, both well below the typical thresholds for healthy returns in the Commodity Chemicals industry. Operating income was negative at -4.66 million CNY, while net income was a modest 13.3 million CNY, indicating that the company is barely profitable despite generating revenue of 2.42 billion CNY. Geographically and segment-wise, the company's exposure is not explicitly detailed in the available data, but the revenue concentration in a single business line (chemicals) suggests a high degree of operational risk. The absence of disclosed geographic diversification or segment breakdowns implies that the company's performance is highly sensitive to regional demand and supply chain disruptions. The company's growth trajectory is uncertain, with no clear revenue growth or margin expansion evident in the latest financials. Capital expenditures were negative at -44.04 million CNY, suggesting asset disposals or underinvestment in growth. Analyst estimates for revenue and EPS are aligned with the reported figures, indicating a lack of upward revision in expectations. Risk factors include a negative net cash position after subtracting total debt, which raises concerns about liquidity and financial flexibility. The company's dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the high price-to-earnings ratio of 1,308.03 and negative EV/EBITDA of -4,038.35 suggest that the stock is not currently valued based on earnings or cash flow generation. Recent events, including filings and transcripts, are not detailed in the available data, but the company's financial performance and capital structure suggest a need for close monitoring of liquidity and operational efficiency. The absence of positive operating cash flow and the presence of negative free cash flow further highlight the need for strategic capital management.
Key takeaways
  • The company is barely profitable with a net income of 13.3 million CNY despite high revenue, indicating weak margins.
  • A debt-to-equity ratio of 0.65 and a current ratio of 1.3 suggest moderate leverage and limited liquidity.
  • The price-to-book ratio of 7.92 and negative EV/EBITDA of -4,038.35 indicate a stock not valued on earnings or cash flow.
  • The company's operational risk is high due to a single business line and lack of geographic or segment diversification.
  • Negative capital expenditures and free cash flow suggest underinvestment in growth and potential asset disposals.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.42B
Gross profit$311.8M
Operating income-$4.7M
Net income$13.3M
R&D
SG&A
D&A
SBC
Operating cash flow$137.5M
CapEx-$44.0M
Free cash flow-$192.1k
Total assets$4.55B
Total liabilities$2.35B
Total equity$2.20B
Cash & equivalents
Long-term debt$1.42B
Valuation
Market price$18.29
Market cap$17.39B
Enterprise value$18.82B
P/E1308.0
Reported non-GAAP P/E
EV/Revenue7.8
EV/Op income
EV/OCF136.8
P/B7.9
P/Tangible book7.9
Tangible book$2.20B
Net cash-$1.42B
Current ratio1.3
Debt/Equity0.7
ROA0.3%
ROE0.6%
Cash conversion10.3%
CapEx/Revenue-1.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002361Activity
Op margin-0.2%0.4% medp25 -8.0% · p75 16.0%below median
Net margin0.5%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin12.9%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity65.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
Last actual EPS0.09 CNY
Last actual revenue1,937,869,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 01:11 UTCJob: e4130256